Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1996 2
1999 2
2000 1
2001 2
2002 2
2003 2
2004 4
2005 7
2006 3
2007 1
2008 6
2009 5
2010 10
2011 12
2012 18
2013 14
2014 11
2015 8
2016 6
2017 9
2018 9
2019 7
2020 6
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 22095945

136 results
Results by year
Filters applied: . Clear all
Page 1
Tubular lesions predict renal outcome in antineutrophil cytoplasmic antibody-associated glomerulonephritis after rituximab therapy.
Berden AE, Jones RB, Erasmus DD, Walsh M, Noël LH, Ferrario F, Waldherr R, Bruijn JA, Jayne DR, Bajema IM; European Vasculitis Society. Berden AE, et al. J Am Soc Nephrol. 2012 Feb;23(2):313-21. doi: 10.1681/ASN.2011040330. Epub 2011 Nov 17. J Am Soc Nephrol. 2012. PMID: 22095945 Free article. Clinical Trial.
Interstitial Immunostaining and Renal Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.
Geetha D, Sethi S, De Vriese AS, Specks U, Kallenberg CGM, Lim N, Spiera R, St Clair EW, Merkel PA, Seo P, Monach PA, Lepori N, Fessler BJ, Langford CA, Hoffman GS, Sharma R, Stone JH, Fervenza FC; RAVE-ITN Research Group. Geetha D, et al. Am J Nephrol. 2017;46(3):231-238. doi: 10.1159/000480443. Epub 2017 Sep 8. Am J Nephrol. 2017. PMID: 28881339 Free PMC article. Clinical Trial.
Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: A prospective analysis of 100 patients with severe renal involvement.
de Lind van Wijngaarden RA, Hauer HA, Wolterbeek R, Jayne DR, Gaskin G, Rasmussen N, Noël LH, Ferrario F, Waldherr R, Hagen EC, Bruijn JA, Bajema IM. de Lind van Wijngaarden RA, et al. J Am Soc Nephrol. 2006 Aug;17(8):2264-74. doi: 10.1681/ASN.2005080870. Epub 2006 Jul 6. J Am Soc Nephrol. 2006. PMID: 16825335 Free article. Clinical Trial.
An index for renal outcome in ANCA-associated glomerulonephritis.
Vergunst CE, van Gurp E, Hagen EC, van Houwelingen HC, Hauer HA, Noël LH, Waldherr R, Ferrario F, van der Woude FJ, Bruijn JA, Bajema IM; EC/BCR Project for ANCA-Assay Standardisation. Vergunst CE, et al. Am J Kidney Dis. 2003 Mar;41(3):532-8. doi: 10.1053/ajkd.2003.50115. Am J Kidney Dis. 2003. PMID: 12612975
Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.
Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ. Hogan SL, et al. J Am Soc Nephrol. 1996 Jan;7(1):23-32. J Am Soc Nephrol. 1996. PMID: 8808106 Free article.
Propylthiouracil-induced antineutrophil cytoplasmic antibody (ANCA)-associated renal vasculitis versus primary ANCA-associated renal vasculitis: a comparative study.
Chen YX, Zhang W, Chen XN, Yu HJ, Ni LY, Xu J, Pan XX, Ren H, Chen N. Chen YX, et al. J Rheumatol. 2012 Mar;39(3):558-63. doi: 10.3899/jrheum.110931. Epub 2012 Jan 15. J Rheumatol. 2012. PMID: 22247359
Histopathologic classification of ANCA-associated glomerulonephritis.
Berden AE, Ferrario F, Hagen EC, Jayne DR, Jennette JC, Joh K, Neumann I, Noël LH, Pusey CD, Waldherr R, Bruijn JA, Bajema IM. Berden AE, et al. J Am Soc Nephrol. 2010 Oct;21(10):1628-36. doi: 10.1681/ASN.2010050477. Epub 2010 Jul 8. J Am Soc Nephrol. 2010. PMID: 20616173 Free article.
[The role of rituximab in the treatment of ANCA-associated systemic vasculitis].
Roccatello D, Vangelista A, Pani A. Roccatello D, et al. G Ital Nefrol. 2011 Sep-Oct;28(5):474-88. G Ital Nefrol. 2011. PMID: 22028261 Review. Italian.
Off-trial evaluation of the B cell-targeting treatment in the refractory cases of antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: long-term follow-up from a single centre.
Pullerits R, Ljevak M, Vikgren J, Bokarewa M. Pullerits R, et al. Scand J Immunol. 2012 Oct;76(4):411-20. doi: 10.1111/j.1365-3083.2012.02747.x. Scand J Immunol. 2012. PMID: 22823472 Free article.
Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
Stasi R, Stipa E, Del Poeta G, Amadori S, Newland AC, Provan D. Stasi R, et al. Rheumatology (Oxford). 2006 Nov;45(11):1432-6. doi: 10.1093/rheumatology/kel098. Epub 2006 Apr 21. Rheumatology (Oxford). 2006. PMID: 16632482 Clinical Trial.
136 results
Jump to page
Feedback